Speaker(s): 

Lindsey Kisielewski, PharmD, Geisinger Pharmacy Resident - has nothing to disclose.

Anye Stevenson, PharmD, Geisinger Pharmacy Resident - has nothing to disclose.

Moderator(s): 

Christopher J DeFrancesco PharmD, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

1. Review the mechanism of action of antiplatelets and anticoagulants in ischemic stroke management
2. Discuss the indications and contraindications for using antiplatelets and anticoagulants in ischemic stroke patients
3. Implement evidence-based strategies for selecting anti-platelets or anticoagulants in clinical practice
4. Identify patient characteristics that influence the choice of antiplatelet or anticoagulant therapy in ischemic stroke

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Christopher DeFrancesco PharmD, RPH, Anil Singh MD, Roop Parlapalli, MD, FHM, FACP, Mary Ellen Berry PA-C, and Carlena Miller CRNP have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None